The Role of p73 in Upper Gastrointestinal Carcinomas
p73 在上消化道癌中的作用
基本信息
- 批准号:6921826
- 负责人:
- 金额:$ 27.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2005-09-30
- 项目状态:已结题
- 来源:
- 关键词:SCID mouseadenocarcinomaathymic mousebiological signal transductionbiomarkercadherinscell lineclinical researchesophagus neoplasmgene expressionhuman subjectimmunocytochemistryneoplasm /cancer geneticsneoplastic processoncogenesp53 gene /proteinpolymerase chain reactionprotein isoformsprotein protein interactionstatistics /biometrystomach neoplasmstranscription factor
项目摘要
DESCRIPTION (provided by applicant): Upper gastrointestinal carcinomas (UGC) are a leading cause of cancer-related morbidity and mortality worldwide. Moreover, the incidences of proximal stomach, gastroesophageal junctional and esophageal adenocarcinomas are the fastest rising of any tumors in the United States and Western World. These tumors are characterized by a poor response to the present chemotherapeutic regiments and an overall low survival rate. The mechanisms of tumorigenesis in upper gastrointestinal tumors are unclear.
p73, a new p53 family member, and its isoform deltaNp73 are increasingly recognized as key players in tumorigenesis, as well as in chemotherapeutic drug sensitivity. Upregulation of these p73 isoforms correlates with poor clinicopathological outcome in several types of tumors. However, in gastrointestinal tumors the role of the p73 gene remains unknown. Our preliminary results indicate that p73 and deltaNp73 transcripts and proteins are frequently overexpressed in UGC. At same time, these proteins have strong oncogenic effects in gastrointestinal cells, as has been demonstrated in our preliminary studies. Taken altogether, these data suggest that p73 and deltaNp73 may be involved in development or progression of UGC. We propose to delineate the role of p73 isoforms in upper gastrointestinal tumorigenesis. In addition, we aim to evaluate their clinical significance. Using a number of cellular and molecular biology techniques, we will characterize the interaction of p73 isoforms with other signaling pathways and investigate the mechanisms that regulate p73 gene expression. For the expression analysis of p73 isoforms in upper gastrointestinal carcinomas, we will employ a real-time RT-PCR analysis and immunohistochemical staining of tumor tissue arrays from our gastrointestinal cancer tissue bank. This information may provide new avenues for the development of novel prognostic and therapeutic targets.
Our specific aims are:
Aim 1: Characterize the clinical significance of p73 isoforms in upper gastrointestinal carcinomas.
Aim 2: Characterize the biological functions of p73 isoforms in upper gastrointestinal adenocarcinomas. Aim 3: Investigate the regulation of p73 gene expression in upper gastrointestinal carcinomas.
描述(由申请人提供):上消化道癌(UGC)是全球癌症相关发病率和死亡率的主要原因。此外,近端胃、胃食管交界处和食管腺癌的发病率在美国和西方世界的任何肿瘤中上升最快。这些肿瘤的特征在于对目前的化疗方案的反应差和总体存活率低。上消化道肿瘤的发生机制尚不清楚。
p73,一个新的p53家族成员,及其亚型deltaNp 73越来越多地被认为是肿瘤发生以及化疗药物敏感性的关键参与者。在几种类型的肿瘤中,这些p73亚型的上调与不良的临床病理结果相关。然而,在胃肠道肿瘤中,p73基因的作用仍然未知。我们的初步研究结果表明,p73和deltaNp 73的转录本和蛋白质经常在UGC中过表达。同时,这些蛋白质在胃肠道细胞中具有强烈的致癌作用,正如我们的初步研究所证明的那样。总之,这些数据表明,p73和deltaNp 73可能参与UGC的发展或进展。我们建议描绘p73亚型在上消化道肿瘤发生中的作用。此外,我们的目的是评估其临床意义。使用一些细胞和分子生物学技术,我们将表征p73亚型与其他信号通路的相互作用,并研究调节p73基因表达的机制。对于p73亚型在上消化道癌中的表达分析,我们将采用实时RT-PCR分析和免疫组化染色的肿瘤组织阵列从我们的胃肠道癌组织库。这些信息可能为开发新的预后和治疗靶点提供新的途径。
我们的具体目标是:
目的1:探讨p73亚型在上消化道恶性肿瘤中的临床意义。
目的2:探讨p73亚型在上消化道腺癌中的生物学功能。目的3:探讨p73基因在上消化道肿瘤中的表达调控。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER I. ZAIKA其他文献
ALEXANDER I. ZAIKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER I. ZAIKA', 18)}}的其他基金
Regulation of the JAK/STAT Signaling and Esophageal Tumorigenesis in Conditions of Esophageal Reflux Injury
食管反流损伤情况下 JAK/STAT 信号传导和食管肿瘤发生的调节
- 批准号:
10662307 - 财政年份:2022
- 资助金额:
$ 27.08万 - 项目类别:
Regulation of the JAK/STAT Signaling and Esophageal Tumorigenesis in Conditions of Esophageal Reflux Injury
食管反流损伤情况下 JAK/STAT 信号传导和食管肿瘤发生的调节
- 批准号:
10407746 - 财政年份:2022
- 资助金额:
$ 27.08万 - 项目类别:
Mechanisms of Tumorigenic Transformation of Barretts Esophagus
Barretts食管致瘤转化机制
- 批准号:
9762032 - 财政年份:2018
- 资助金额:
$ 27.08万 - 项目类别:
Mechanisms of Tumorigenic Transformation of Barretts Esophagus
Barretts食管致瘤转化机制
- 批准号:
9326930 - 财政年份:2015
- 资助金额:
$ 27.08万 - 项目类别:
Mechanisms of Tumorigenic Transformation of Barretts Esophagus
Barretts食管致瘤转化机制
- 批准号:
9150649 - 财政年份:2015
- 资助金额:
$ 27.08万 - 项目类别:
Mechanisms of Tumorigenic Transformation of Barretts Esophagus
Barretts食管致瘤转化机制
- 批准号:
9132990 - 财政年份:2015
- 资助金额:
$ 27.08万 - 项目类别:
Mechanisms of Tumorigenic Transformation of Barretts Esophagus
Barretts食管致瘤转化机制
- 批准号:
9248180 - 财政年份:2015
- 资助金额:
$ 27.08万 - 项目类别:
Regulation of DNA damage response in esophageal cells exposed to reflux
反流食管细胞 DNA 损伤反应的调节
- 批准号:
10514576 - 财政年份:2014
- 资助金额:
$ 27.08万 - 项目类别:
Regulation of gastroesophageal reflux-associated tumorigenesis
胃食管反流相关肿瘤发生的调节
- 批准号:
8732012 - 财政年份:2014
- 资助金额:
$ 27.08万 - 项目类别:
Regulation of DNA damage response in esophageal cells exposed to reflux
反流食管细胞 DNA 损伤反应的调节
- 批准号:
10012259 - 财政年份:2014
- 资助金额:
$ 27.08万 - 项目类别:
相似国自然基金
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
- 批准号:82372007
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 27.08万 - 项目类别:
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别:
Risk stratifying indeterminate pulmonary nodules with jointly learned features from longitudinal radiologic and clinical big data
利用纵向放射学和临床大数据共同学习的特征对不确定的肺结节进行风险分层
- 批准号:
10678264 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别:
Console Upgrade for 4.7T PET-MRI Preclinical Scanner
4.7T PET-MRI 临床前扫描仪控制台升级
- 批准号:
10630520 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别:
The role of focal adhesion kinase in therapy resistant prostate tumors
粘着斑激酶在治疗耐药性前列腺肿瘤中的作用
- 批准号:
10638034 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别:
WASHINGTON UNIVERSITY HUMAN TUMOR ATLAS RESEARCH CENTER
华盛顿大学人类肿瘤阿特拉斯研究中心
- 批准号:
10819927 - 财政年份:2023
- 资助金额:
$ 27.08万 - 项目类别: